Kailera Therapeutics, Inc. (KLRA) stock
KLRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$11.79−0.41 (-3.36%)
Close on Nov 18, 2026Market cap $1.53BP/E –Yield –
Kailera Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Kailera Therapeutics's market cap was $1.86B on Nov 11, 2026.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.86B | – |
See a number that looks wrong?